RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients.

Maurenis Hernandez; Eduardo Rafael Santiesteban; Ramon Alberto Ortiz; Elia Neninger; Soraida Acosta; Yoana Flores; Rosa Maria Amador; Mayte Robaina; Ivis Mendoza; Pedro Pablo Guerra; Anet Valdes; Ana Maria Vazquez; Amparo Macias; Tania Crombet

doi:10.1200/jco.2014.32.15_suppl.tps3111

RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps3111 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS3111-TPS3111

Author(s):

Maurenis Hernandez ◽

Eduardo Rafael Santiesteban ◽

Ramon Alberto Ortiz ◽

Elia Neninger ◽

Soraida Acosta ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial ◽

Lung Cancer Patients

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Cited By ~ 14

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdf316 ◽

2002 ◽

Vol 13 (12) ◽

pp. 1853-1861 ◽

Cited By ~ 44

Author(s):

P.J. Souquet ◽

E.H. Tan ◽

J. Rodrigues Pereira ◽

R. Van Klaveren ◽

A. Price ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Lung Cancer Patients ◽

Clinical Phase

Download Full-text

Individualized Adaptive Radiotherapy versus Standard Radiotherapy with Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer: A Multicenter Randomized Phase III Clinical Trial CRTOG1601

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2286 ◽

2020 ◽

Vol 108 (3) ◽

pp. S105

Author(s):

S. Yuan ◽

Q. Yu ◽

S. Wang ◽

Y. Xu ◽

H. Ge ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Adaptive Radiotherapy ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial

Download Full-text

Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181da36db ◽

2010 ◽

Vol 5 (7) ◽

pp. 1042-1047 ◽

Cited By ~ 6

Author(s):

Nobuyuki Yamamoto ◽

Yutaka Nishiwaki ◽

Shunichi Negoro ◽

Haiyi Jiang ◽

Yohji Itoh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Control ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial

European Radiology ◽

10.1007/s00330-019-06613-x ◽

2020 ◽

Vol 30 (5) ◽

pp. 2692-2702 ◽

Cited By ~ 2

Author(s):

Zhigang Wei ◽

Xia Yang ◽

Xin Ye ◽

Qingliang Feng ◽

Yanjun Xu ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Microwave Ablation ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial ◽

Randomized Controlled

Download Full-text

Randomized Phase III Trial of Gefitinib versus Docetaxel in Non-Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-1903 ◽

2010 ◽

Vol 16 (4) ◽

pp. 1307-1314 ◽

Cited By ~ 123

Author(s):

D. H. Lee ◽

K. Park ◽

J. H. Kim ◽

J.-S. Lee ◽

S. W. Shin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Lung Cancer Patients ◽

Platinum Based Chemotherapy

Download Full-text

EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial

Therapy ◽

10.2217/thy.10.83 ◽

2011 ◽

Vol 8 (1) ◽

pp. 55-61 ◽

Cited By ~ 1

Author(s):

Geoffrey Y Ku ◽

Gilberto de Lima Jopes Jr

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial

Download Full-text

Faculty Opinions recommendation of Shifting patterns in the interpretation of phase III clinical trial outcomes in advanced non-small-cell lung cancer: the bar is dropping.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718297778.793492020 ◽

2014 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial ◽

Trial Outcomes

Download Full-text

CYTAR: A randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib-induced folliculitis in non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.9019 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 9019-9019 ◽

Cited By ~ 12

Author(s):

G. Deplanque ◽

J. Chavaillon ◽

A. Vergnenegre ◽

L. Falchero ◽

G. Fraboulet ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Randomized Clinical Trial ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Preventive Effect ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(99)00120-8 ◽

2000 ◽

Vol 28 (2) ◽

pp. 97-107 ◽

Cited By ~ 27

Author(s):

J Sacristán

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Economic Evaluation ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial

Download Full-text